Novel therapeutics for diabetic retinopathy and diabetic macular edema: a pathophysiologic perspective

KL Bunch, AA Abdelrahman, RB Caldwell… - Frontiers in …, 2022 - frontiersin.org
Diabetic retinopathy (DR) and diabetic macular edema (DME) are retinal complications of
diabetes that can lead to loss of vision and impaired quality of life. The current gold standard …

The evolving treatment options for diabetic macular edema

A Jain, N Varshney, C Smith - International Journal of …, 2013 - Wiley Online Library
Diabetic retinopathy (DR) is the leading cause of vision loss in working‐age adults, and
diabetic macular edema (DME) is the most common cause of visual impairment in …

Pharmacologic therapies for diabetic retinopathy and diabetic macular edema

E Rechtman, A Harris, HJ Garzozi… - Clinical ophthalmology, 2007 - Taylor & Francis
Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of
blindness in the working-aged population of most developed countries. The increasing …

Emerging pharmacotherapies for diabetic macular edema

BA Furlani, CH Meyer, EB Rodrigues… - Expert opinion on …, 2007 - Taylor & Francis
Diabetic macular edema (DME) is the most frequent cause of severe vision impairment in
patients with non-proliferative diabetic retinopathy. Even though patients should achieve …

Pathophysiology of diabetic macular edema

AP Cabrera, EL Wolinsky, RN Mankad… - Diabetic Macular …, 2023 - Springer
The unique structural organization of the retinal microvasculature is essential for the healthy
maintenance of the retina. Primarily responsible for the regulation of vascular permeability …

Current concepts of pharmacotherapy of diabetic macular edema

C Haritoglou, M Maier, AS Neubauer… - Expert opinion on …, 2020 - Taylor & Francis
Introduction: Diabetic macular edema (DME) is a sight threatening disease and a major
cause for blindness for people in working age. The pathogenesis is multifactorial and …

Diabetic macular edema: current understanding, molecular mechanisms and therapeutic implications

J Zhang, J Zhang, C Zhang, J Zhang, L Gu, D Luo… - Cells, 2022 - mdpi.com
Diabetic retinopathy (DR), with increasing incidence, is the major cause of vision loss and
blindness worldwide in working-age adults. Diabetic macular edema (DME) remains the …

Diabetic macular edema: pathophysiology and novel therapeutic targets

A Das, PG McGuire, S Rangasamy - Ophthalmology, 2015 - Elsevier
Diabetic macular edema (DME) is the major cause of vision loss in diabetic persons.
Alteration of the blood–retinal barrier is the hallmark of this disease, characterized by …

Diabetic Retinopathy/Diabetic Macular Edema

OIR OIR - 2010 - pharmalegacy.com
Diabetic retinopathy (DR) and diabetic macular edema (DME) represent a significant
complication duo, threatening vision and impacting millions of diabetic patients worldwide …

Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies

TA Ciulla, AG Amador, B Zinman - Diabetes care, 2003 - Am Diabetes Assoc
Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of
blindness in the working-age population of most developed countries. The increasing …